New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 7, 2026 (HealthDay News) — Ozempic and Wegovy might help people avoid ...

Furthermore, GLP-1 drugs had a favorable safety profile versus aspirin, particularly with respect to bleeding events, said ...

SAN FRANCISCO -- Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated ...

A breast cancer drug paired with venetoclax significantly enhanced leukemia cell killing and durability in preclinical tests.

# “While aspirin has been studied for colorectal cancer prevention, its modest benefit and bleeding risks limit its use.

Opportunities in the colorectal cancer drugs market include growth in targeted therapy and immunotherapy, advancements in ...

Diabetes is an ongoing medical condition that affects millions of people across the globe. Blood sugar needs to be controlled ...

Low dose of a hot flush medication (megestrol acetate) halts breast cancer growth, providing an economical way to improve ...

Florida Cancer Specialists & Research Institute, LLC (FCS) advances gastrointestinal cancer treatment through participation ...

Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...

A recent study revealed that GLP-1 drugs, Ozempic and Wegovy, primarily used for diabetes and weight loss, may assist in ...